Literature DB >> 4029009

In vitro activity of temocillin against clinical isolates.

H W Van Landuyt, J Boelaert, P Piot, L Verbist.   

Abstract

The minimum inhibitory concentrations of temocillin against more than 1000 clinical isolates were determined by an agar dilution method. Temocillin showed excellent activity against Haemophilus influenzae, pathogenic Neisseria species and Branhamella catarrhalis, including beta-lactamase producing strains, but showed very low activity or was inactive against Gram-positive cocci and Campylobacter, Bacteroides, Acinetobacter and Pseudomonas species. Good activity was obtained against 702 Enterobacteriaceae, including isolates resistant to the other penicillins and first- and second-generation cephalosporins, with 92% of all the strains inhibited at a concentration of 8 mg/L. However, the most striking property of temocillin was its high beta-lactamase stability which resulted in both a very narrow range of MICs within which all the isolates were inhibited, and a small influence of inoculum size on the MICs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029009     DOI: 10.2165/00003495-198500295-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  6 in total

1.  BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

Authors:  B Slocombe; M J Basker; P H Bentley; J P Clayton; M Cole; K R Comber; R A Dixon; R A Edmondson; D Jackson; D J Merrikin; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

2.  The pharmacokinetics of temocillin in patients with normal and impaired renal function.

Authors:  J Boelaert; R Daneels; M Schurgers; A M Lambert; H W Van Landuyt; G Mellows; J Wolf; A J Swaisland
Journal:  J Antimicrob Chemother       Date:  1983-04       Impact factor: 5.790

3.  In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

4.  Comparative in vitro activities of temocillin and cefazolin against Klebsiella pneumoniae.

Authors:  H Lagast; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

5.  In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.

Authors:  P Piot; E Van Dyck
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

6.  In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic.

Authors:  H W Van Landuyt; M Pyckavet; A Lambert; J Boelaert
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

  6 in total
  3 in total

Review 1.  Pharmacokinetics and Pharmacodynamics of Temocillin.

Authors:  Kevin Alexandre; Bruno Fantin
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

2.  In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units.

Authors:  Y Glupczynski; T-D Huang; C Berhin; G Claeys; M Delmée; L Ide; G Ieven; D Pierard; H Rodriguez-Villalobos; M Struelens; J Vaneldere
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11       Impact factor: 3.267

Review 3.  Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C M Perry; R N Brogden
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.